Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1996 Aug 17;313(7054):407–411. doi: 10.1136/bmj.313.7054.407

Neonatal screening for sickle cell disorders: what about the carrier infants?

L Laird 1, C Dezateux 1, E N Anionwu 1
PMCID: PMC2351830  PMID: 8761233

Full text

PDF
407

Images in this article

408Fig 1
on p.408
409Fig 3
on p.409
409Fig 4
on p.409
411p411-a
on p.411

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adjaye N., Bain B. J., Steer P. Prediction and diagnosis of sickling disorders in neonates. Arch Dis Child. 1989 Jan;64(1 Spec No):39–43. doi: 10.1136/adc.64.1_spec_no.39. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anionwu E. N. Sickle cell and thalassaemia: some priorities for nursing research. J Adv Nurs. 1996 May;23(5):853–856. doi: 10.1111/j.1365-2648.1996.tb00061.x. [DOI] [PubMed] [Google Scholar]
  3. Antley M. A., Antley R. M., Hartlage L. C. Effects of genetic counseling on parental self-concepts. J Psychol. 1973 Mar;83(2D):335–338. doi: 10.1080/00223980.1973.9915623. [DOI] [PubMed] [Google Scholar]
  4. Ballas S. K., Park D., Wapner R. J. Neonatal screening for sickle cell disease in a metropolitan university hospital: efficacy and problems. J Med Screen. 1994 Oct;1(4):229–232. doi: 10.1177/096914139400100409. [DOI] [PubMed] [Google Scholar]
  5. Billings P. R., Kohn M. A., de Cuevas M., Beckwith J., Alper J. S., Natowicz M. R. Discrimination as a consequence of genetic testing. Am J Hum Genet. 1992 Mar;50(3):476–482. [PMC free article] [PubMed] [Google Scholar]
  6. Brock D. J., Shrimpton A. E. Non-paternity and prenatal genetic screening. Lancet. 1991 Nov 2;338(8775):1151–1151. doi: 10.1016/0140-6736(91)92013-r. [DOI] [PubMed] [Google Scholar]
  7. Choiseul M., Allen A., May A. Training and needs of health visitors in the haemoglobinopathies. Health Visit. 1988 Jul;61(7):205–206. [PubMed] [Google Scholar]
  8. Clarke A. The genetic testing of children. Working Party of the Clinical Genetics Society (UK) J Med Genet. 1994 Oct;31(10):785–797. doi: 10.1136/jmg.31.10.785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dalby S. GIG response to the UK Clinical Genetics Society report "The genetic testing of children". J Med Genet. 1995 Jun;32(6):490–491. doi: 10.1136/jmg.32.6.490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Githens J. H., Lane P. A., McCurdy R. S., Houston M. L., McKinna J. D., Cole D. M. Newborn screening for hemoglobinopathies in Colorado. The first 10 years. Am J Dis Child. 1990 Apr;144(4):466–470. doi: 10.1001/archpedi.1990.02150280088018. [DOI] [PubMed] [Google Scholar]
  11. Griffiths P. D., Mann J. R., Darbyshire P. J., Green A. Evaluation of eight and a half years of neonatal screening for haemoglobinopathies in Birmingham. Br Med J (Clin Res Ed) 1988 Jun 4;296(6636):1583–1585. doi: 10.1136/bmj.296.6636.1583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Grossman L. K., Holtzman N. A., Charney E., Schwartz A. D. Neonatal screening and genetic counseling for sickle cell trait. Am J Dis Child. 1985 Mar;139(3):241–244. doi: 10.1001/archpedi.1985.02140050035016. [DOI] [PubMed] [Google Scholar]
  13. Hampton M. L., Anderson J., Lavizzo B. S., Bergmen A. B. Sickle cell "nondisease". A potentially serious public health problem. Am J Dis Child. 1974 Jul;128(1):58–61. [PubMed] [Google Scholar]
  14. Horn M. E., Dick M. C., Frost B., Davis L. R., Bellingham A. J., Stroud C. E., Studd J. W. Neonatal screening for sickle cell diseases in Camberwell: results and recommendations of a two year pilot study. Br Med J (Clin Res Ed) 1986 Mar 15;292(6522):737–740. doi: 10.1136/bmj.292.6522.737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hurst D. Newborn screening for sickle cell disease and other hemoglobinopathies. Northern California's experience. Pediatrics. 1989 May;83(5 Pt 2):868–871. [PubMed] [Google Scholar]
  16. Jinks D. C., Minter M., Tarver D. A., Vanderford M., Hejtmancik J. F., McCabe E. R. Molecular genetic diagnosis of sickle cell disease using dried blood specimens on blotters used for newborn screening. Hum Genet. 1989 Mar;81(4):363–366. doi: 10.1007/BF00283692. [DOI] [PubMed] [Google Scholar]
  17. Lorey F., Cunningham G., Shafer F., Lubin B., Vichinsky E. Universal screening for hemoglobinopathies using high-performance liquid chromatography: clinical results of 2.2 million screens. Eur J Hum Genet. 1994;2(4):262–271. doi: 10.1159/000472370. [DOI] [PubMed] [Google Scholar]
  18. Macintyre S., Sooman A. Non-paternity and prenatal genetic screening. Lancet. 1991 Oct 5;338(8771):869–871. doi: 10.1016/0140-6736(91)91513-t. [DOI] [PubMed] [Google Scholar]
  19. Markel H. The stigma of disease: implications of genetic screening. Am J Med. 1992 Aug;93(2):209–215. doi: 10.1016/0002-9343(92)90052-d. [DOI] [PubMed] [Google Scholar]
  20. Marteau T., Michie S. Genetic testing for familial hypertrophic cardiomyopathy in newborn infants. A positive screening test for an untreatable condition provides psychological relief from uncertainty. BMJ. 1995 Jul 1;311(6996):58–59. doi: 10.1136/bmj.311.6996.58c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. McCabe E. R., Huang S. Z., Seltzer W. K., Law M. L. DNA microextraction from dried blood spots on filter paper blotters: potential applications to newborn screening. Hum Genet. 1987 Mar;75(3):213–216. doi: 10.1007/BF00281061. [DOI] [PubMed] [Google Scholar]
  22. Papadea C., Eckman J. R., Kuehnert R. S., Platt A. F. Comparison of liquid and dried blood for neonatal hemoglobinopathy screening: laboratory and programmatic issues. Pediatrics. 1994 Mar;93(3):427–432. [PubMed] [Google Scholar]
  23. Pelias M. Z. Duty to disclose in medical genetics: a legal perspective. Am J Med Genet. 1991 Jun 1;39(3):347–354. doi: 10.1002/ajmg.1320390320. [DOI] [PubMed] [Google Scholar]
  24. Rowley P. T. Parental receptivity to neonatal sickle trait identification. Pediatrics. 1989 May;83(5 Pt 2):891–893. [PubMed] [Google Scholar]
  25. Shickle D., May A. Knowledge and perceptions of haemoglobinopathy carrier screening among general practitioners in Cardiff. J Med Genet. 1989 Feb;26(2):109–112. doi: 10.1136/jmg.26.2.109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Smith Tony. Genes and ethics. BMJ. 1995 Aug 26;311(7004):574–574. doi: 10.1136/bmj.311.7004.574a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Statham H., Green J., Snowdon C. Mothers' consent to screening newborn babies for disease. BMJ. 1993 Mar 27;306(6881):858–859. doi: 10.1136/bmj.306.6881.858-c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Wooldridge E. Q., Murray R. F., Jr The Health Orientation Scale: a measure of feelings about sickle cell trait. Soc Biol. 1988 Spring-Summer;35(1-2):123–136. doi: 10.1080/19485565.1988.9988694. [DOI] [PubMed] [Google Scholar]
  29. Zeesman S., Clow C. L., Cartier L., Scriver C. R. A private view of heterozygosity: eight-year follow-up study on carriers of the Tay-Sachs gene detected by high school screening in Montreal. Am J Med Genet. 1984 Aug;18(4):769–778. doi: 10.1002/ajmg.1320180424. [DOI] [PubMed] [Google Scholar]
  30. Zhang Y. H., McCabe E. R. RNA analysis from newborn screening dried blood specimens. Hum Genet. 1992 May;89(3):311–314. doi: 10.1007/BF00220548. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES